Transphorm (TGAN)
(Delayed Data from NSDQ)
$4.89 USD
+0.02 (0.41%)
Updated May 9, 2024 04:00 PM ET
After-Market: $4.88 -0.01 (-0.20%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Transphorm, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 17 | 24 | 0 | 11 |
Cost Of Goods | NA | 17 | 13 | 0 | 7 |
Gross Profit | NA | -1 | 12 | 0 | 5 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 28 | 21 | 0 | 18 |
Income After Depreciation & Amortization | 0 | -29 | -10 | 0 | -13 |
Non-Operating Income | NA | -1 | 0 | 0 | -4 |
Interest Expense | NA | 1 | 1 | 0 | 1 |
Pretax Income | NA | -31 | -10 | 0 | -18 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -31 | -10 | 0 | -18 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -31 | -10 | 0 | -18 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -27 | -9 | 0 | -13 |
Depreciation & Amortization (Cash Flow) | NA | 2 | 1 | 0 | 1 |
Income After Depreciation & Amortization | 0 | -29 | -10 | 0 | -13 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 56.23 | 46.06 | 36.57 | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.50 | -0.22 | -0.42 | NA |
Diluted Net EPS (GAAP) | NA | -0.54 | -0.22 | -0.56 | -0.56 |
Fiscal Year end for Transphorm, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 4.67 | 5.01 | 5.88 | 3.19 |
Cost Of Goods | NA | 4.60 | 3.84 | 3.80 | 3.02 |
Gross Profit | NA | 0.08 | 1.17 | 2.09 | 0.18 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 9.00 | 7.67 | 8.87 | 8.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -8.92 | -6.50 | -6.78 | -8.34 |
Non-Operating Income | NA | -1.08 | -0.63 | -0.66 | -0.27 |
Interest Expense | NA | 0.00 | 0.00 | 0.01 | 0.18 |
Pretax Income | NA | -10.00 | -7.13 | -7.45 | -8.79 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -10.00 | -7.13 | -7.45 | -8.79 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -10.00 | -7.13 | -7.45 | -8.79 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 62.18 | 61.14 | 59.26 | 57.14 |
Diluted EPS Before Non-Recurring Items | NA | -0.20 | -0.12 | -0.11 | -0.14 |
Diluted Net EPS (GAAP) | NA | -0.20 | -0.12 | -0.22 | -0.16 |